Once damaged, it has limited ability to heal, leaving millions of people worldwide with permanent paralysis. However, a groundbreaking clinical trial in Japan has provided a glimmer of hope, showing ...

The significant drop in CNS Pharmaceuticals’ stock price reflects investor concerns over the commercial viability of Berubicin following these trial results. The company’s next steps will likely be ...

There is a growing opportunity to expand clinical research capacity in Africa, and numerous organisations are contributing to this effort. To name a few: the African Medicines Agency provides ...

The following is a summary of "Redefining Clinical Trial Strategic Design to Support Drug Approval in Medical Oncology” ...